Get the Stockscreener App
381.70
0.03%
0.12
Overview
News
Price History
Option Chain
Financials
Why MSFT Down?
Discussions
Forecast
Stock Split
Dividend History
Microsoft Corp stock is traded at $381.70, with a volume of 27.54M.
It is up +0.03% in the last 24 hours and up +4.44% over the past month.
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
See More
Previous Close:
$381.58
Open:
$387.05
24h Volume:
27.54M
Relative Volume:
0.72
Market Cap:
$2.84T
Revenue:
$318.27B
Net Income/Loss:
$125.22B
P/E Ratio:
22.73
EPS:
16.79
Net Cash Flow:
$72.92B
1W Performance:
-3.08%
1M Performance:
+4.44%
6M Performance:
-18.08%
1Y Performance:
-25.29%
1-Day Range:
$380.65
$389.03
1-Week Range:
$377.39
$403.18
52-Week Range:
$349.20
$555.45
Microsoft Corp Stock (MSFT) Company Profile
Name
Microsoft Corp
Sector
Industry
Phone
425-882-8080
Address
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT vs ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corp
|
381.70 | 2.84T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
114.99 | 331.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
122.92 | 294.68B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
183.28 | 186.63B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
152.37 | 111.63B | 7.11B | 1.95B | 2.44B | 2.5883 |
Microsoft Corp Stock (MSFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-26 | Resumed | Morgan Stanley | Overweight |
| Jul-20-26 | Initiated | CLSA | Outperform |
| Jul-10-26 | Reiterated | Argus | Buy |
| Jun-01-26 | Initiated | Citizens | Mkt Outperform |
| Apr-30-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-30-26 | Reiterated | Barclays | Overweight |
| Apr-30-26 | Reiterated | Bernstein | Outperform |
| Apr-30-26 | Reiterated | Citigroup | Buy |
| Apr-30-26 | Reiterated | Deutsche Bank | Buy |
| Apr-30-26 | Reiterated | Evercore ISI | Outperform |
| Apr-30-26 | Reiterated | Piper Sandler | Overweight |
| Apr-30-26 | Reiterated | Stifel | Hold |
| Apr-30-26 | Reiterated | The Benchmark Company | Buy |
| Apr-30-26 | Reiterated | Truist | Buy |
| Apr-30-26 | Reiterated | Wells Fargo | Overweight |
| Apr-28-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-26 | Reiterated | Citigroup | Buy |
| Apr-15-26 | Reiterated | Robert W. Baird | Outperform |
| Apr-14-26 | Reiterated | Mizuho | Outperform |
| Apr-14-26 | Reiterated | Piper Sandler | Overweight |
| Mar-25-26 | Reiterated | UBS | Buy |
| Mar-24-26 | Resumed | BofA Securities | Buy |
| Feb-09-26 | Downgrade | Melius | Buy → Hold |
| Feb-05-26 | Downgrade | Stifel | Buy → Hold |
| Feb-03-26 | Resumed | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-29-26 | Reiterated | Barclays | Overweight |
| Jan-29-26 | Reiterated | Bernstein | Outperform |
| Jan-29-26 | Reiterated | Citigroup | Buy |
| Jan-29-26 | Reiterated | Deutsche Bank | Buy |
| Jan-29-26 | Reiterated | Evercore ISI | Outperform |
| Jan-29-26 | Reiterated | Goldman | Buy |
| Jan-29-26 | Reiterated | JP Morgan | Overweight |
| Jan-29-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-29-26 | Reiterated | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-29-26 | Reiterated | Stifel | Buy |
| Jan-29-26 | Reiterated | Wedbush | Outperform |
| Jan-29-26 | Reiterated | Wells Fargo | Overweight |
| Jan-26-26 | Reiterated | Stifel | Buy |
| Jan-23-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Citigroup | Buy |
| Jan-21-26 | Reiterated | Mizuho | Outperform |
| Jan-12-26 | Reiterated | Barclays | Overweight |
| Jan-12-26 | Resumed | Goldman | Buy |
| Jan-08-26 | Reiterated | Wells Fargo | Overweight |
| Nov-18-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Nov-14-25 | Initiated | Robert W. Baird | Outperform |
| Oct-30-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-27-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-22-25 | Reiterated | Citigroup | Buy |
| Oct-17-25 | Reiterated | Mizuho | Outperform |
| Oct-06-25 | Reiterated | Wells Fargo | Overweight |
| Jul-31-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-31-25 | Reiterated | Barclays | Overweight |
| Jul-31-25 | Reiterated | Bernstein | Outperform |
| Jul-31-25 | Reiterated | BofA Securities | Buy |
| Jul-31-25 | Reiterated | Jefferies | Buy |
| Jul-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-31-25 | Reiterated | Mizuho | Outperform |
| Jul-31-25 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-25 | Reiterated | Oppenheimer | Outperform |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-31-25 | Reiterated | UBS | Buy |
| Jul-31-25 | Reiterated | Wedbush | Outperform |
| Jul-31-25 | Reiterated | Wells Fargo | Overweight |
| Jul-22-25 | Reiterated | Citigroup | Buy |
| Jul-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-16-25 | Reiterated | Mizuho | Outperform |
| Jul-09-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-02-25 | Reiterated | DA Davidson | Buy |
| Jun-25-25 | Reiterated | Wedbush | Outperform |
| Jun-11-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | BMO Capital Markets | Outperform |
| May-01-25 | Reiterated | Barclays | Overweight |
| May-01-25 | Reiterated | Evercore ISI | Outperform |
| May-01-25 | Reiterated | Goldman | Buy |
| May-01-25 | Reiterated | JP Morgan | Overweight |
| May-01-25 | Reiterated | Mizuho | Outperform |
| May-01-25 | Reiterated | Piper Sandler | Overweight |
| May-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| May-01-25 | Reiterated | Raymond James | Outperform |
| May-01-25 | Reiterated | Scotiabank | Sector Outperform |
| May-01-25 | Reiterated | Stifel | Buy |
| May-01-25 | Reiterated | Wedbush | Outperform |
| Apr-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-16-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-14-25 | Reiterated | UBS | Buy |
| Apr-14-25 | Reiterated | Wells Fargo | Overweight |
| Mar-20-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-13-25 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-25 | Reiterated | Piper Sandler | Overweight |
| Oct-31-24 | Reiterated | BMO Capital Markets | Outperform |
| Oct-10-24 | Reiterated | Goldman | Buy |
| Oct-08-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-23-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-10-24 | Initiated | New Street | Buy |
| Jun-07-24 | Reiterated | Oppenheimer | Outperform |
| Apr-17-24 | Reiterated | Wells Fargo | Overweight |
| Apr-12-24 | Reiterated | BMO Capital Markets | Outperform |
| Apr-11-24 | Reiterated | Morgan Stanley | Overweight |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-18-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-13-23 | Initiated | Truist | Buy |
| Dec-05-23 | Initiated | China Renaissance | Buy |
| Oct-26-23 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-17-23 | Initiated | Loop Capital | Buy |
| Sep-25-23 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-15-23 | Initiated | HSBC Securities | Hold |
| Jul-24-23 | Reiterated | Goldman | Buy |
| Jul-24-23 | Reiterated | Raymond James | Outperform |
| Jul-21-23 | Reiterated | Goldman | Buy |
| Jul-19-23 | Reiterated | Barclays | Overweight |
| Jul-19-23 | Reiterated | BofA Securities | Buy |
| Jul-19-23 | Reiterated | Mizuho | Buy |
| Jul-19-23 | Reiterated | TD Cowen | Outperform |
| Jul-19-23 | Reiterated | Wells Fargo | Overweight |
| Jul-17-23 | Reiterated | Mizuho | Buy |
| Jul-14-23 | Upgrade | UBS | Neutral → Buy |
| Jul-13-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-26-23 | Reiterated | Goldman | Buy |
| Apr-26-23 | Reiterated | Guggenheim | Sell |
| Apr-26-23 | Reiterated | JP Morgan | Overweight |
| Apr-26-23 | Reiterated | Jefferies | Buy |
| Apr-26-23 | Upgrade | Macquarie | Neutral → Outperform |
| Apr-26-23 | Reiterated | Mizuho | Buy |
| Apr-26-23 | Reiterated | MoffettNathanson | Market Perform |
| Apr-26-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-26-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Reiterated | Piper Sandler | Overweight |
| Apr-26-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-26-23 | Reiterated | Raymond James | Outperform |
| Apr-26-23 | Reiterated | Rosenblatt | Buy |
| Apr-26-23 | Reiterated | Stifel | Buy |
| Apr-26-23 | Reiterated | TD Cowen | Outperform |
| Apr-26-23 | Reiterated | UBS | Neutral |
| Apr-26-23 | Reiterated | Wedbush | Outperform |
| Apr-26-23 | Reiterated | Wells Fargo | Overweight |
| Apr-26-23 | Reiterated | Wolfe Research | Outperform |
| Apr-24-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Apr-21-23 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Jan-25-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-17-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-05-23 | Initiated | DA Davidson | Buy |
| Jan-04-23 | Downgrade | UBS | Buy → Neutral |
| Nov-02-22 | Initiated | Macquarie | Neutral |
| Oct-14-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Resumed | Raymond James | Outperform |
| Sep-22-22 | Initiated | MoffettNathanson | Hold |
| Aug-12-22 | Initiated | Guggenheim | Neutral |
| Jul-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-22 | Reiterated | Citigroup | Buy |
| Jul-27-22 | Reiterated | Cowen | Outperform |
| Jul-27-22 | Reiterated | Deutsche Bank | Buy |
| Jul-27-22 | Reiterated | Stifel | Buy |
| Jul-27-22 | Reiterated | Wedbush | Outperform |
| Jul-26-22 | Initiated | Itau BBA | Outperform |
| Jul-19-22 | Reiterated | Citigroup | Buy |
| Jun-29-22 | Initiated | Redburn | Buy |
| Apr-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Apr-27-22 | Reiterated | Deutsche Bank | Buy |
| Apr-27-22 | Reiterated | Evercore ISI | In-line |
| Apr-27-22 | Reiterated | Stifel | Buy |
| Apr-27-22 | Reiterated | Wedbush | Outperform |
| Apr-27-22 | Reiterated | Wolfe Research | Outperform |
| Jan-26-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-26-22 | Reiterated | Citigroup | Buy |
| Jan-26-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-26-22 | Reiterated | Oppenheimer | Outperform |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-22-21 | Initiated | SMBC Nikko | Outperform |
| Nov-22-21 | Initiated | Wells Fargo | Overweight |
| Nov-16-21 | Resumed | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Buy |
| Oct-27-21 | Reiterated | Barclays | Overweight |
| Oct-27-21 | Reiterated | BofA Securities | Buy |
| Oct-27-21 | Reiterated | Cowen | Outperform |
| Oct-27-21 | Reiterated | Credit Suisse | Outperform |
| Oct-27-21 | Reiterated | Goldman | Buy |
| Oct-27-21 | Reiterated | Mizuho | Buy |
| Oct-27-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-27-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Reiterated | Stifel | Buy |
| Sep-17-21 | Resumed | Rosenblatt | Buy |
| Sep-14-21 | Reiterated | Morgan Stanley | Overweight |
| Aug-20-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Barclays | Overweight |
| Jul-28-21 | Reiterated | Bernstein | Outperform |
| Jul-28-21 | Reiterated | BofA Securities | Buy |
| Jul-28-21 | Reiterated | Citigroup | Buy |
| Jul-28-21 | Reiterated | Cowen | Outperform |
| Jul-28-21 | Reiterated | Credit Suisse | Outperform |
| Jul-28-21 | Reiterated | Griffin Securities | Buy |
| Jul-28-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-28-21 | Reiterated | Piper Sandler | Overweight |
| Jul-28-21 | Resumed | RBC Capital Mkts | Outperform |
| Jul-28-21 | Reiterated | Rosenblatt | Buy |
| Jul-28-21 | Reiterated | Stifel | Buy |
| Jul-28-21 | Reiterated | Wolfe Research | Outperform |
| Jul-22-21 | Reiterated | BofA Securities | Buy |
| Jul-22-21 | Reiterated | Citigroup | Buy |
| Jul-22-21 | Reiterated | Cowen | Outperform |
| Jul-22-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jun-23-21 | Reiterated | Wedbush | Outperform |
| May-13-21 | Initiated | Rosenblatt | Buy |
| Apr-23-21 | Initiated | Wolfe Research | Outperform |
| Apr-12-21 | Reiterated | BMO Capital Markets | Outperform |
| Apr-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-03-21 | Resumed | Citigroup | Buy |
| Jan-26-21 | Resumed | Raymond James | Strong Buy |
| Jan-22-21 | Initiated | Goldman | Buy |
| Dec-21-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Buy |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-14-20 | Resumed | UBS | Buy |
| Jul-23-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-20-20 | Reiterated | Stifel | Buy |
| Jul-15-20 | Reiterated | BMO Capital Markets | Outperform |
| Jul-09-20 | Reiterated | Wedbush | Outperform |
| Jun-24-20 | Reiterated | Argus | Buy |
| Jun-02-20 | Reiterated | Wells Fargo | Overweight |
| May-27-20 | Initiated | Summit Insights | Buy |
| Apr-30-20 | Reiterated | Griffin Securities | Buy |
| Jan-30-20 | Reiterated | Oppenheimer | Outperform |
| Jan-30-20 | Reiterated | Piper Sandler | Overweight |
| Jan-30-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-30-20 | Reiterated | Raymond James | Strong Buy |
| Jan-30-20 | Reiterated | Stifel | Buy |
| Jan-30-20 | Reiterated | Wedbush | Outperform |
| Jan-30-20 | Reiterated | Wells Fargo | Overweight |
View All
Microsoft Corp Stock (MSFT) Latest News
Down 34% From Its Highs, Is Marvell Technology a Buy on the Dip? - The Motley Fool
Microsoft Seeks To Pause Or Exit Teams BIPA 'Voiceprint' Suit - Law360
Nvidia, Microsoft urge US to avoid broad restrictions on open AI models - Fox Business
NVIDIA, Microsoft Lead Push for Open AI Models After Kimi K3 Launch - Yahoo! Finance Canada
Microsoft Stock (MSFT) Opinions on Morgan Stanley Analyst Coverage - Quiver Quantitative
Nvidia, Microsoft lead call for open-weight AI models after Kimi - Fortune
Microsoft Stock Before Q4 Earnings: Buy Now or Wait for Results? - Yahoo Finance Singapore
Nvidia, Microsoft Lead Call for Open-Weight AI Models After Kimi - Bloomberg.com
Microsoft Corp. Revenue Breakdown – SIX:MSFT - TradingView
Meta, Microsoft Face Renewed Unease Over AI Spending: US Earnings Week Ahead - Bloomberg.com
Microsoft Q4 Earnings Will Be A Buying Opportunity (NASDAQ:MSFT) - Seeking Alpha
Microsoft Corp (NASDAQ:MSFT) Stands Out as a Quality Dividend Stock on the Best Dividend Stocks Screen - ChartMill
Microsoft Corp (MSFT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Microsoft is replacing OpenAI image models in PowerPoint, Bing - The Star
Microsoft Corp (MSFT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MSFT|Microsoft Corp|Price:381.730|Chg%:+0.150 - TradingKey
MSFT|Microsoft Corp|Price:381.540|Chg%:-8.800 - TradingKey
Microsoft And Meta Earnings Previews - Seeking Alpha
Microsoft fiber foul-up cut off Azure California for almost five hours - The Register
silicon diversity powers Azure AI infrastructure - SiliconANGLE
Amazon vs. Microsoft: Which Cloud Empire Is the Better Buy Now? - The Motley Fool
Microsoft Earnings Preview: Get Ready for Soaring AI Spending to Sink MSFT Stock - Barchart.com
Databricks and Microsoft Expand Partnership to Help Enterprises Bring Business Context to Enterprise AI - HPCwire
Wedbush Sees AMD’s Microsoft Deal as the Start of a Sharp AI Ramp, But It’s Not a Reason to Dive In Here - Barchart.com
Microsoft replaces OpenAI image models with its own technology - Investing.com
Hilton Head Capital Partners, LLC's Microsoft Corp(MSFT) Holding History - GuruFocus
Microsoft replaces OpenAI image models with its own technology By Investing.com - Investing.com Nigeria
Databricks and Microsoft expand partnership to help enterprises bring business context to enterprise AI - Investing News Network
Microsoft Is Replacing OpenAI Image Models in PowerPoint, Bing - Bloomberg.com
Databricks and Microsoft expand Azure partnership into the 2030s - SiliconANGLE
Microsoft Stock Sits 11% Below Its 200-Day Average as Earnings Approach - Benzinga
Microsoft Just Validated AMD’s Biggest AI Bet. This Could Be the Start of a New Growth Phase for AMD Stock. - Barchart.com
Oppenheimer Issues Stark Message on Microsoft Stock Ahead of Earnings - Yahoo Finance
Microsoft Corp (MSFT) Institutional Confidence - TradingKey
Microsoft Corp Q4 2026 earnings preview - ig.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors with Losses to Secure Counsel Before Important August 4 Deadline in Securities Class Action - GlobeNewswire Inc.
CapEx Is in Focus for Microsoft Stock Ahead of Q4 Earnings, But the Bull Case Remains Strong - Barchart.com
Microsoft Analysts Say Stock is Deeply Undervalued Ahead of Q4 Earnings - Benzinga
Analysts Say Microsoft Stock is Deeply Undervalued Ahead of Q4 Earnings - Benzinga
Microsoft Is Deepening Ties with AI Giant Mistral. What That Actually Means for MSFT Stock Investors. - Barchart.com
Chinese asylum-seeker accused of draining elderly NY woman’s $360K life savings in fake Microsoft scam - Fox Business
Microsoft: How To Deal With 2.5 Years Of Dead Money (NASDAQ:MSFT) - Seeking Alpha
MICROSOFT CORP SEC Filing (Jul 22, 2026) - Stock Titan
Microsoft Corp Stock (MSFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.21%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):